VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹18 Cr | ₹60 Cr | ₹58 Cr | ₹46 Cr | ₹58 Cr |
What is the latest Total Non-Current Liabilities ratio of VENUS REMEDIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹60 Cr |
| Mar2023 | ₹58 Cr |
| Mar2022 | ₹46 Cr |
| Mar2021 | ₹58 Cr |
How is Total Non-Current Liabilities of VENUS REMEDIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 Cr | -69.12 | |
| Mar2024 | ₹60 Cr | 2.89 | |
| Mar2023 | ₹58 Cr | 26.60 | |
| Mar2022 | ₹46 Cr | -20.94 | |
| Mar2021 | ₹58 Cr | - | |
Compare Total Non-Current Liabilities of peers of VENUS REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VENUS REMEDIES | ₹1,005.3 Cr | -3.9% | -12.2% | 153% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹393,323.0 Cr | -2.5% | -7% | -8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,825.0 Cr | -2.2% | -7.2% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,349.0 Cr | -4% | 2.8% | 27.1% | Stock Analytics | |
| CIPLA | ₹106,048.0 Cr | -5.5% | -12.4% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,494.0 Cr | 5.9% | -3.7% | -6.5% | Stock Analytics | |
VENUS REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VENUS REMEDIES | -3.9% |
-12.2% |
153% |
| SENSEX | -2.4% |
-4.7% |
6.4% |
You may also like the below Video Courses